Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis

Journal of Cardiovascular Computed Tomography

Volumn 9, Issue 6, 2015, Pages 585-592

  Treibel, Thomas A ^a,b   Bandula, Steve ^b   Fontana, Marianna ^a,b   White, Steven K ^a,b   Gilbertson, Janet A ^b   Herrey, Anna S ^b   Gillmore, Julian D ^b   Punwani, Shonit ^b   Hawkins, Philip N ^b   Taylor, Stuart A ^b   Moon, James C ^a,b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Amyloidosis; Cardiac imaging techniques; CCT; CMR; Extracellular space

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CONTRAST MEDIUM; IODIXANOL; IODOBENZOIC ACID DERIVATIVE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); TROPONIN;

ADULT; AGED; AMYLOIDOSIS; BIOPSY; BLOOD; BONE; CARDIAC GATED IMAGING; CARDIOMYOPATHY; CASE CONTROL STUDY; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; ECHOGRAPHY; ELECTROCARDIOGRAPHY; EXTRACELLULAR SPACE; FEMALE; HEART; HUMAN; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; SCINTISCANNING; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; AMYLOIDOSIS; BIOMARKERS; BIOPSY; BONE AND BONES; CARDIAC-GATED IMAGING TECHNIQUES; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; CONTRAST MEDIA; ELECTROCARDIOGRAPHY; EXTRACELLULAR SPACE; FEMALE; HEART; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; RADIONUCLIDE IMAGING; SEVERITY OF ILLNESS INDEX; TRIIODOBENZOIC ACIDS; TROPONIN; ULTRASONOGRAPHY;

EID: 84949313779     PISSN: 19345925     EISSN: 1876861X     Source Type: Journal    
DOI: 10.1016/j.jcct.2015.07.001     Document Type: Article

References (26)

1. Banypersad S.M., Moon J.C., Whelan C., Hawkins P.N., Wechalekar A.D. Updates in cardiac amyloidosis: a review. J Am Heart Assoc. 2012, 1:e000364.
2. Merlini G., Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003, 349:583-596.
3. Ng B., Connors L.H., Davidoff R., Skinner M., Falk R.H. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med 2005, 165:1425-1429.
4. Dubrey S.W., Cha K., Skinner M., LaValley M., Falk R.H. Familial and primary (al) cardiac amyloidosis: Echocardiographically similar diseases with distinctly different clinical outcomes. Heart 1997, 78:74-82.
5. Rapezzi C., Merlini G., Quarta C.C., et al. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 2009, 120:1203-1212.
6. Hanna M. Novel drugs targeting transthyretin amyloidosis. Curr Heart Fail Rep 2014 Mar, 11(1):50-57.
7. Wechalekar A.D., Hawkins P.N. Al amyloidosis: new drugs and tests, but old challenges. Oncology (Williston Park) 2012, 26. 161-162, 164.
8. Syed I.S., Glockner J.F., Feng D., et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging 2010, 3:155-164.
9. Pinney J.H., Whelan C.J., Petrie A., et al. Senile systemic amyloidosis: clinical features at presentation and outcome. J Am Heart Assoc. 2013, 2:e000098.
10. Perugini E., Guidalotti P.L., Salvi F., et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mtc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol 2005, 46:1076-1084.
11. Hutt D.F., Quigley A.M., Page J., et al. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. Eur Heart J Cardiovasc Imaging 2014.
12. Maceira A.M., Prasad S.K., Hawkins P.N., Roughton M., Pennell D.J. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 2008, 10:54.
13. Banypersad S.M., Sado D.M., Flett A.S., et al. Quantification of myocardial extracellular volume fraction in systemic al amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging 2013, 6:34-39.
14. Bandula S., White S.K., Flett A.S., et al. Measurement of myocardial extracellular volume fraction by using equilibrium contrast-enhanced ct: validation against histologic findings. Radiology 2013, 269:396-403.
15. Nacif M.S., Kawel N., Lee J.J., et al. Interstitial myocardial fibrosis assessed as extracellular volume fraction with low-radiation-dose cardiac ct. Radiology 2012, 264:876-883.
16. Nacif M.S., Liu Y., Yao J., et al. 3d left ventricular extracellular volume fraction by low-radiation dose cardiac ct: assessment of interstitial myocardial fibrosis. J Cardiovasc Comput Tomogr 2013, 7:51-57.
17. Nagueh S.F., Appleton C.P., Gillebert T.C., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009, 10:165-193.
18. Gertz M.A., Comenzo R., Falk R.H., et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (al): a consensus opinion from the 10th international symposium on amyloid and amyloidosis, tours, france, 18-22 april 2004. Am J Hematol 2005, 79:319-328.
19. Fontana M., Banypersad S.M., Treibel T.A., et al. Native t1 mapping in transthyretin amyloidosis. JACC Cardiovasc Imaging 2014, 7:157-165.
20. Hausleiter J., Meyer T., Hermann F., et al. Estimated radiation dose associated with cardiac ct angiography. Jama 2009, 301:500-507.
21. Piechnik S.K., Ferreira V.M., Dall'Armellina E., et al. Shortened modified look-locker inversion recovery (shmolli) for clinical myocardial t1-mapping at 1.5 and 3 t within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 2010, 12:69.
22. Flett A.S., Hayward M.P., Ashworth M.T., et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 2010, 122:138-144.
23. Moon J.C., Messroghli D.R., Kellman P., et al. Myocardial t1 mapping and extracellular volume quantification: a society for cardiovascular magnetic resonance (scmr) and cmr working group of the european society of cardiology consensus statement. J Cardiovasc Magn Reson 2013, 15:92.
24. Sado D.M., Flett A.S., Banypersad S.M., et al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 2012, 98:1436-1441.
25. Kuruvilla S., Janardhanan R., Antkowiak P., et al. Increased extracellular volume and altered mechanics are associated with lvh in hypertensive heart disease, not hypertension alone. JACC Cardiovasc Imaging 2015, 8:172-180.
26. Brouwer W.P., Baars E.N., Germans T., et al. In-vivo t1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2014, 16:28.